Testing an mRNA Ebola-Bundibugyo vaccine in healthy adults
Part of Infections clinical trials.
This study tests a new mRNA vaccine (mRNA-1469) to prevent Ebola-Bundibugyo virus disease. It is for healthy adults to see if the vaccine is safe and produces an immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health or have stable chronic medical conditions.
- Your body mass index (BMI) is between 18.5 and 39.
- If you are a woman of childbearing age, you are not pregnant or breastfeeding and agree to use contraception.
- You have never had a severe allergic reaction to any mRNA vaccine.
- You have never been in an Ebola vaccine study before.
- You have not been exposed to or infected with Ebola or similar viruses, and have not traveled to an affected area in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether it is safe and effective to give an Ebola vaccine at the same time as a COVID-19 booster shot. It may help find a way to protect against both diseases with fewer clinic visits.
This trial tests two new mRNA vaccines for Japanese encephalitis, a brain infection spread by mosquitoes. It aims to find the safest and most effective dose in healthy adults, with a first stage in younger adults and a second stage in all adults.
This trial tests an experimental mRNA vaccine (mRNA-1189) to see if it can prevent Epstein-Barr virus (EBV) infection. It is for healthy adults 18 to 30 years old.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
This trial tests an Ebola vaccine in healthy people from local communities to see how it works and how safe it is. You may be able to join if you meet age, health, and vaccination/medication rules and can follow pregnancy-prevention and consent requirements.
Hear when a new Ebola-Bundibugyo Virus Disease (Ebola-BDBV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.